SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

Share Price is delayed by 15 minutes
Get Live Data
0.944    0.00 (0.00%)
Bid:
0.944
Ask:
0.946
Spread: 0.002 (0.212%)
Market Cap: $1.06b
BPCR Live PriceLast checked at - London Stock Exchange

Intraday Biopharma Cred. Share Chart

Director/PDMR Shareholding

16 Apr 2026 17:59

RNS Number : 8348A
BioPharma Credit PLC
16 April 2026
 

BIOPHARMA CREDIT PLC

 

Notification of Transactions by

Persons Discharging Managerial Responsibilities and

Persons Closely Associated with them

 

1.

Details of person discharging managerial responsibilities/person closely associated with them

a)

Name

Anita Hyman

2.

Reason for the notification

a)

Position / status

Person Closely Associated with Harry Hyman (Director of BioPharma Credit PLC)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

BioPharma Credit PLC

b)

LEI

213800AV55PYXAS7SY24

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares of $0.01 each

 

 

GB00BDGKMY29

b)

Nature of the transaction

Purchase of Shares (acquired as part of dividend reinvestment)

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.701281

137

d)

Aggregated information

- Aggregated volume

 

- Price

 

 

N/A

 

 

e)

Date of the transaction

23.03.2026

f)

Place of the transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLGDSLUBDGLL
Date   Source Headline
20th Oct 20226:15 pmRNSTransaction in Own Shares
20th Oct 20227:00 amRNSNew US$140.0 Million Investment
18th Oct 20226:15 pmRNSTransaction in Own Shares
17th Oct 20226:15 pmRNSTransaction in Own Shares
14th Oct 20226:15 pmRNSTransaction in Own Shares
14th Oct 20225:44 pmRNSHolding(s) in Company
13th Oct 20226:15 pmRNSTransaction in Own Shares
13th Oct 20227:00 amRNSSPECIAL DIVIDEND DECLARATION AND NET ASSET VALUES
7th Oct 20226:15 pmRNSTransaction in Own Shares
6th Oct 20226:29 pmRNSTransaction in Own Shares
6th Oct 20227:00 amRNSStatement re Global Blood Therapeutics, Inc.
5th Oct 20226:15 pmRNSTransaction in Own Shares
4th Oct 20226:15 pmRNSTransaction in Own Shares
3rd Oct 20226:15 pmRNSTransaction in Own Shares
3rd Oct 20227:00 amRNSTotal Voting Rights
30th Sep 20226:15 pmRNSTransaction in Own Shares
29th Sep 20226:15 pmRNSTransaction in Own Shares
28th Sep 20226:15 pmRNSTransaction in Own Shares
27th Sep 20226:15 pmRNSTransaction in Own Shares
26th Sep 20226:15 pmRNSTransaction in Own Shares
23rd Sep 20226:15 pmRNSTransaction in Own Shares
22nd Sep 20226:15 pmRNSTransaction in Own Shares
22nd Sep 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
20th Sep 20226:15 pmRNSTransaction in Own Shares
16th Sep 20226:15 pmRNSTransaction in Own Shares
15th Sep 20226:15 pmRNSTransaction in Own Shares
14th Sep 20227:00 amRNSHalf-yearly Report
14th Sep 20227:00 amRNSSTATEMENT RE SAREPTA THERAPEUTICS, INC.
31st Aug 20227:00 amRNSNotice of Half Year Results
22nd Aug 20224:53 pmRNSStatement re Epizyme
19th Aug 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
16th Aug 20227:00 amRNSDividend Declaration
9th Aug 20227:00 amRNSSTATEMENT RE GLOBAL BLOOD THERAPEUTICS
21st Jul 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
20th Jul 202211:11 amRNSStatement Re Akebia
11th Jul 20227:00 amRNSTransaction in Own Shares
8th Jul 20227:00 amRNSTransaction in Own Shares
6th Jul 20225:36 pmRNSTransaction in Own Shares
5th Jul 20225:40 pmRNSTransaction in Own Shares
1st Jul 20227:00 amRNSSHARE BUY-BACK PROGRAMME
28th Jun 20227:00 amRNSSTATEMENT RE EPIZYME
23rd Jun 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
9th Jun 20225:39 pmRNSResult of AGM
23rd May 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
13th May 202212:35 pmRNSNotice of AGM
5th May 202210:25 amRNSDirector/PDMR Shareholding
27th Apr 20225:15 pmRNSDividend Declaration
26th Apr 202211:36 amRNSHolding(s) in Company
25th Apr 20224:00 pmRNSNet Asset Value(s) and Monthly Factsheet
21st Apr 20223:18 pmRNSResults of Placing in BioPharma Credit Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.